New CDC Study Slated To Assess PFAS Effects On COVID Vaccine Efficacy

The Centers for Disease Control and Prevention (CDC) has launched a series of studies to assess the excess risks from the coronavirus faced by those exposed to per- and polyfluoroalkyl substances (PFAS), including a new study of healthcare workers and first responders that could help determine vaccine efficacy and duration just as the first vaccines are poised for approval. Robert Redfield, director of the CDC and of the Agency for Toxic Substances and Disease Registry (ATSDR), told Rep. Dan Kildee...